Beijing Pharmaceutical, a subsidiary of China Resources Medications Group, plans to list on the Hong Kong Stock Exchange, one more piece of evidence that Hong Kong is the exchange of choice for large China pharma IPOs. As yet, the size of the offering is not known. However, Beijing Pharma’s revenues are expected to hit 16 billion RMB ($2.4 billion) in 2010, up from 10 billion ($1.5 billion) in 2009. More details....